Tata Elxsi, 3 other large and mid cap stocks crossed 100-day SMA

In the ever-fluctuating world of stock markets, investors are always on the lookout for key indicators to guide their decisions. The Simple Moving Average (SMA) is one such vital indicator, and crossing the 100-day SMA can offer valuable insights into a stock's short to intermediate-term performance. On Friday, October 13, four significant players in the Indian stock market - Tata Elxsi, Torrent Pharmaceuticals, Apollo Hospitals Enterprise, and Endurance Technologies - crossed their 100-day SMA, indicating a potential change in their trends.

Let's explore the performance of these stocks. (Data Source: StockEdge)

1. Tata Elxsi

Tata Elxsi is a renowned name in the technology consulting industry, offering innovative design and engineering solutions. With a 100-day SMA of 7387.17 and a closing price of 7443.75 on October 13, the stock has not only crossed its 100-day SMA but has done so with an impressive margin.

2. Torrent Pharmaceuticals
Torrent Pharmaceuticals is a key player in the pharmaceutical sector, known for its high-quality medications and diverse product range. With a 100-day SMA of 1890.99 and a closing price of 1895.6 on October 13, Torrent Pharmaceuticals is showing strength as it crosses its 100-day SMA.

3. Apollo Hospitals Enterprise
Apollo Hospitals Enterprise is a significant contributor to India's healthcare sector, with a vast network of hospitals, pharmacies, and diagnostic centers. With a 100-day SMA of 5012.42 and a closing price of 5017.3 on October 13, the stock has surpassed its 100-day SMA, indicating a promising path ahead.

4. Endurance Technologies
Endurance Technologies is a leading name in the automotive component manufacturing industry, serving various well-known vehicle manufacturers. With a 100-day SMA of 1600.77 and a closing price of 1601.9 on October 13, the stock has demonstrated strength by surpassing its 100-day SMA, implying positive sentiment among investors.

(Disclaimer: This is an AI-generated article. Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)